# OnCo record olympia (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/olympia/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "olympia", "NCT02032823" ;
  schema:name "OlympiA"@en ;
  schema:description "Showed that a year of a PARP inhibitor after standard treatment improves survival in women with inherited BRCA mutations."@en ;
  schema:url <https://onco.cc/trials/olympia/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02032823>, <https://doi.org/10.1016/j.annonc.2022.09.159>, <https://www.nice.org.uk/guidance/ta886>, <https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22LYNPARZA%22> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2014-04-22" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc-early/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/>, <https://onco.cc/companies/big/>, <https://onco.cc/companies/breast-cancer-trials/> ;
  onco:people <https://onco.cc/people/andrew-tutt/>, <https://onco.cc/people/charles-geyer/>, <https://onco.cc/people/judy-garber/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-olympia-nejm-2021/> .